dc.creatorGomes, Irênio
dc.creatorMelo, Ailton
dc.creatorProietti, Fernando Augusto
dc.creatorCarvalho, Otavio Augusto Moreno
dc.creatorLoures, Luiz Antonio M
dc.creatorDazza, Marie Christine
dc.creatorSaid, Gerard
dc.creatorLarouzé, Bernard
dc.creatorCastro Filho, Bernardo Galvão
dc.date2014-08-07T18:55:33Z
dc.date2014-08-07T18:55:33Z
dc.date1999
dc.date.accessioned2023-09-26T22:59:48Z
dc.date.available2023-09-26T22:59:48Z
dc.identifierGOMES, I. et al. Human T lymphotropic virus type I (HTLV-I) infection in neurological patients in Salvador, Bahia, Brazil. Journal of the Neurological Sciences, v. 165, n. 1, p. 84–89, 1999.
dc.identifier0022-510X
dc.identifierhttps://www.arca.fiocruz.br/handle/icict/8152
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8885656
dc.descriptionHTLV-I infection represents a major health concern in endemic areas throughout the world, such as Salvador, the main city of Bahia State, with socio-demographic characteristics similar to sub-Saharan African cities, located in the Northeast of Brazil. In order to provide an estimate of the frequency distribution, and range of neurological manifestations potentially related to HTLV-I infection in this city, we conducted a cross-sectional clinical-epidemiological study to determine the prevalence of this infection in patients with neurological diseases. Patients exhibiting vascular diseases, tumoral diseases or trauma were excluded. Over a period of 16 months, we studied 322 consecutive patients with chronic neurological diseases, who attended the neurological clinics of two major hospitals in Salvador. Overall, the prevalence of HTLV-I infection among the patients was 20.9% (67/320). However, the prevalence among the 104 patients with chronic myelopathy was 50.0% (52/104). It was observed that the major prevalence of HTLV-I was between the ages of 40 and 60 years with a female predominance. Our data indicate that, in Salvador city, HTLV-I is associated with chronic myelopathies or myeloneuropathies, which seem to be the only neurological diseases associated with HTLV-I.
dc.formatapplication/pdf
dc.languageeng
dc.publisherElsevier
dc.rightsopen access
dc.subjectHTLV-I
dc.subjectNeurological diseases
dc.subjectTSP
dc.subjectHAM
dc.subjectPrevalence
dc.subjectSouth America
dc.subjectInfecções por HTLV-I/epidemiologia
dc.subjectDoenças do Sistema Nervoso/epidemiologia
dc.subjectAdolescente
dc.subjectAdulto
dc.subjectBrasil/epidemiologia
dc.subjectAnticorpos Antibacterianos/análise
dc.subjectEstudos Transversais
dc.subjectAnticorpos Antideltaretrovirus/análise
dc.subjectFeminino
dc.subjectAnticorpos Anti-HIV/análise
dc.subjectInfecções por HTLV-I/líquido cefalorraquidiano
dc.subjectInfecções por HTLV-I/diagnóstico
dc.subjectHumanos
dc.subjectMasculino
dc.subjectMeia-Idade
dc.subjectDoenças do Sistema Nervoso/diagnóstico
dc.subjectEstudos Soroepidemiológicos
dc.subjectTreponema pallidum/imunologia
dc.titleHuman T lymphotropic virus type I (HTLV-I) infection in neurological patients in Salvador, Bahia, Brazil.
dc.typeArticle


Este ítem pertenece a la siguiente institución